Toyonaka, Japan

Nobuhiko Tamura


Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 486(Granted Patents)


Location History:

  • Ibaraki, JP (1991)
  • Toyonaka, JP (1987 - 1993)

Company Filing History:


Years Active: 1987-1993

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Nobuhiko Tamura: Innovator in Controlled Release Formulations

Introduction

Nobuhiko Tamura is a distinguished inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of nine patents to his name, Tamura's work has had a notable impact on drug delivery systems.

Latest Patents

One of Tamura's latest patents is focused on a controlled release formulation. This formulation comprises a compound selected from organic acidic compounds and acid anhydrides or esters capable of generating one of the organic acidic compounds through hydrolysis. It also includes an active ingredient and collagen as a carrier, allowing the formulation to exhibit a predetermined release profile of the active ingredient. Another significant patent involves aminoazole derivatives, detailing a compound formula and its production and use.

Career Highlights

Throughout his career, Nobuhiko Tamura has worked with prominent companies such as Sumitomo Pharmaceuticals Company Limited and Nissho Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and formulations.

Collaborations

Tamura has collaborated with notable coworkers, including Keiji Fujioka and Yoshihiro Takada. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Nobuhiko Tamura's innovative work in controlled release formulations and his collaborations with esteemed colleagues highlight his significant contributions to the field of pharmaceuticals. His nine patents reflect a commitment to advancing drug delivery systems, making him a key figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…